nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.00108	0.00108	CbGpPWpGaD
Temsirolimus—MTOR—IRS-mediated signalling—HRAS—salivary gland cancer	0.00108	0.00108	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—ATM—salivary gland cancer	0.00107	0.00107	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ISYNA1—salivary gland cancer	0.00107	0.00107	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—PTEN—salivary gland cancer	0.00105	0.00105	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.00105	0.00105	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events—HRAS—salivary gland cancer	0.00105	0.00105	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—PI-3K cascade—PIK3CA—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—HRAS—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—PTEN—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—PI3K/AKT activation—PIK3CA—salivary gland cancer	0.00101	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—HRAS—salivary gland cancer	0.00101	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—HRAS—salivary gland cancer	0.00101	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—GAB1 signalosome—PIK3CA—salivary gland cancer	0.00101	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—PTEN—salivary gland cancer	0.000996	0.000996	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.000995	0.000995	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—FGFR4—salivary gland cancer	0.000993	0.000993	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—PTEN—salivary gland cancer	0.000991	0.000991	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—PTEN—salivary gland cancer	0.000986	0.000986	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—PTEN—salivary gland cancer	0.000986	0.000986	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—PIK3CA—salivary gland cancer	0.000984	0.000984	CbGpPWpGaD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—PIK3CA—salivary gland cancer	0.000984	0.000984	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—PTEN—salivary gland cancer	0.000981	0.000981	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—PTEN—salivary gland cancer	0.000976	0.000976	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—PIK3CA—salivary gland cancer	0.000969	0.000969	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ST3GAL4—salivary gland cancer	0.000962	0.000962	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—salivary gland cancer	0.000962	0.000962	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—FGFR4—salivary gland cancer	0.000953	0.000953	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—JAG1—salivary gland cancer	0.000953	0.000953	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TP53—salivary gland cancer	0.000952	0.000952	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—FGFR4—salivary gland cancer	0.000949	0.000949	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—DTX4—salivary gland cancer	0.000946	0.000946	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—FBXW7—salivary gland cancer	0.000938	0.000938	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CREBBP—salivary gland cancer	0.000934	0.000934	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—FBXW7—salivary gland cancer	0.000934	0.000934	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PTEN—salivary gland cancer	0.000918	0.000918	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—PTEN—salivary gland cancer	0.000918	0.000918	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—PTEN—salivary gland cancer	0.000918	0.000918	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—PIK3CA—salivary gland cancer	0.000915	0.000915	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—HRAS—salivary gland cancer	0.00091	0.00091	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—HRAS—salivary gland cancer	0.00091	0.00091	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—PTEN—salivary gland cancer	0.00091	0.00091	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—PIK3CA—salivary gland cancer	0.000908	0.000908	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—PTEN—salivary gland cancer	0.000902	0.000902	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FGF16—salivary gland cancer	0.0009	0.0009	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—PTEN—salivary gland cancer	0.000898	0.000898	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—HRAS—salivary gland cancer	0.000897	0.000897	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00089	0.00089	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—WNT5B—salivary gland cancer	0.000889	0.000889	CbGpPWpGaD
Temsirolimus—MTOR—Disease—DTX4—salivary gland cancer	0.000874	0.000874	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MARCKS—salivary gland cancer	0.000872	0.000872	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL17RD—salivary gland cancer	0.000859	0.000859	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CYLD—salivary gland cancer	0.000856	0.000856	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—PTEN—salivary gland cancer	0.00085	0.00085	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—HRAS—salivary gland cancer	0.000846	0.000846	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—HRAS—salivary gland cancer	0.00084	0.00084	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.00083	0.00083	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—FOXO3—salivary gland cancer	0.000824	0.000824	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PRKDC—salivary gland cancer	0.000821	0.000821	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PTEN—salivary gland cancer	0.000813	0.000813	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PYGB—salivary gland cancer	0.000811	0.000811	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—FOXO3—salivary gland cancer	0.000791	0.000791	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—FOXO3—salivary gland cancer	0.000788	0.000788	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAML3—salivary gland cancer	0.000785	0.000785	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FGF16—salivary gland cancer	0.000783	0.000783	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAML2—salivary gland cancer	0.000782	0.000782	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	0.000777	0.000777	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ISYNA1—salivary gland cancer	0.000773	0.000773	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NUP62—salivary gland cancer	0.00075	0.00075	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—PIK3CA—salivary gland cancer	0.000744	0.000744	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000732	0.000732	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FGF16—salivary gland cancer	0.000723	0.000723	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.000719	0.000719	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000712	0.000712	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—HRAS—salivary gland cancer	0.000707	0.000707	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—PIK3CA—salivary gland cancer	0.000702	0.000702	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MC3R—salivary gland cancer	0.0007	0.0007	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—PIK3CA—salivary gland cancer	0.000699	0.000699	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—PIK3CA—salivary gland cancer	0.000695	0.000695	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NUP62—salivary gland cancer	0.000693	0.000693	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—PIK3CA—salivary gland cancer	0.000692	0.000692	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—PIK3CA—salivary gland cancer	0.000689	0.000689	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	0.000688	0.000688	CbGpPWpGaD
Temsirolimus—MTOR—Disease—VCAN—salivary gland cancer	0.000687	0.000687	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—salivary gland cancer	0.000679	0.000679	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—HRAS—salivary gland cancer	0.000677	0.000677	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000674	0.000674	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000673	0.000673	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—MAP2K2—salivary gland cancer	0.000673	0.000673	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—JAG1—salivary gland cancer	0.000667	0.000667	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FGFR4—salivary gland cancer	0.000665	0.000665	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PHGDH—salivary gland cancer	0.000661	0.000661	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FBXW7—salivary gland cancer	0.000654	0.000654	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—HRAS—salivary gland cancer	0.00065	0.00065	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	0.000648	0.000648	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	0.000648	0.000648	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—PIK3CA—salivary gland cancer	0.000648	0.000648	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—HRAS—salivary gland cancer	0.000647	0.000647	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—HRAS—salivary gland cancer	0.000643	0.000643	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—HRAS—salivary gland cancer	0.000643	0.000643	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MAP2K2—salivary gland cancer	0.000643	0.000643	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—PIK3CA—salivary gland cancer	0.000642	0.000642	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—HRAS—salivary gland cancer	0.00064	0.00064	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—HRAS—salivary gland cancer	0.000637	0.000637	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	0.000636	0.000636	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—EP300—salivary gland cancer	0.000636	0.000636	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ST3GAL4—salivary gland cancer	0.000636	0.000636	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—PIK3CA—salivary gland cancer	0.000634	0.000634	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MARCKS—salivary gland cancer	0.00063	0.00063	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—salivary gland cancer	0.000628	0.000628	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MAML2—salivary gland cancer	0.000628	0.000628	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—PTEN—salivary gland cancer	0.000626	0.000626	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DTX4—salivary gland cancer	0.000612	0.000612	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—PIK3CA—salivary gland cancer	0.0006	0.0006	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—HRAS—salivary gland cancer	0.000599	0.000599	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.000599	0.000599	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—HRAS—salivary gland cancer	0.000599	0.000599	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000599	0.000599	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—HRAS—salivary gland cancer	0.000594	0.000594	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	0.000589	0.000589	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—HRAS—salivary gland cancer	0.000586	0.000586	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PYGB—salivary gland cancer	0.000586	0.000586	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.000583	0.000583	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FGFR4—salivary gland cancer	0.000578	0.000578	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AQP1—salivary gland cancer	0.000578	0.000578	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000574	0.000574	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FBXW7—salivary gland cancer	0.000569	0.000569	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—HRAS—salivary gland cancer	0.000555	0.000555	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FOXO3—salivary gland cancer	0.000552	0.000552	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	0.00055	0.00055	CbGpPWpGaD
Temsirolimus—MTOR—Disease—JAG1—salivary gland cancer	0.000536	0.000536	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FGFR4—salivary gland cancer	0.000534	0.000534	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000533	0.000533	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000531	0.000531	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NOTCH1—salivary gland cancer	0.000527	0.000527	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FBXW7—salivary gland cancer	0.000525	0.000525	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000521	0.000521	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGF16—salivary gland cancer	0.000506	0.000506	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CREBBP—salivary gland cancer	0.0005	0.0005	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FOXO3—salivary gland cancer	0.00048	0.00048	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CREBBP—salivary gland cancer	0.000478	0.000478	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PHGDH—salivary gland cancer	0.000478	0.000478	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CDH1—salivary gland cancer	0.000476	0.000476	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000476	0.000476	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ST3GAL4—salivary gland cancer	0.00046	0.00046	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—NUP62—salivary gland cancer	0.000458	0.000458	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—TP53—salivary gland cancer	0.000455	0.000455	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—VCAN—salivary gland cancer	0.000454	0.000454	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAP2K2—salivary gland cancer	0.00045	0.00045	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MARCKS—salivary gland cancer	0.000448	0.000448	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FOXO3—salivary gland cancer	0.000443	0.000443	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PYGB—salivary gland cancer	0.000442	0.000442	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—PIK3CA—salivary gland cancer	0.000441	0.000441	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAML2—salivary gland cancer	0.00044	0.00044	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AQP1—salivary gland cancer	0.000417	0.000417	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PYGB—salivary gland cancer	0.000417	0.000417	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—HRAS—salivary gland cancer	0.000408	0.000408	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MAP2K2—salivary gland cancer	0.000392	0.000392	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000385	0.000385	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—JAG1—salivary gland cancer	0.000375	0.000375	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGFR4—salivary gland cancer	0.000374	0.000374	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000372	0.000372	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000369	0.000369	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FBXW7—salivary gland cancer	0.000368	0.000368	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MAP2K2—salivary gland cancer	0.000362	0.000362	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.00036	0.00036	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000359	0.000359	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—PTEN—salivary gland cancer	0.000357	0.000357	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000355	0.000355	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000347	0.000347	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—PTEN—salivary gland cancer	0.000343	0.000343	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTEN—salivary gland cancer	0.000341	0.000341	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EP300—salivary gland cancer	0.00034	0.00034	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PHGDH—salivary gland cancer	0.00034	0.00034	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CREBBP—salivary gland cancer	0.000335	0.000335	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NUP62—salivary gland cancer	0.000331	0.000331	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—VCAN—salivary gland cancer	0.000328	0.000328	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	0.000327	0.000327	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—EP300—salivary gland cancer	0.000325	0.000325	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000315	0.000315	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FOXO3—salivary gland cancer	0.00031	0.00031	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AQP1—salivary gland cancer	0.000297	0.000297	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOTCH1—salivary gland cancer	0.000296	0.000296	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000293	0.000293	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CREBBP—salivary gland cancer	0.000291	0.000291	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDH1—salivary gland cancer	0.000289	0.000289	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000272	0.000272	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CREBBP—salivary gland cancer	0.000269	0.000269	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000262	0.000262	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000254	0.000254	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAP2K2—salivary gland cancer	0.000253	0.000253	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—PIK3CA—salivary gland cancer	0.000252	0.000252	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NUP62—salivary gland cancer	0.00025	0.00025	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000248	0.000248	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCND1—salivary gland cancer	0.000248	0.000248	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000242	0.000242	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PIK3CA—salivary gland cancer	0.000241	0.000241	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PTEN—salivary gland cancer	0.000239	0.000239	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NUP62—salivary gland cancer	0.000235	0.000235	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—VCAN—salivary gland cancer	0.000234	0.000234	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—HRAS—salivary gland cancer	0.000233	0.000233	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EP300—salivary gland cancer	0.000228	0.000228	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HRAS—salivary gland cancer	0.000224	0.000224	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HRAS—salivary gland cancer	0.000223	0.000223	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000222	0.000222	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000214	0.000214	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PTEN—salivary gland cancer	0.000208	0.000208	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOTCH1—salivary gland cancer	0.000208	0.000208	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000207	0.000207	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EP300—salivary gland cancer	0.000198	0.000198	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000194	0.000194	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTEN—salivary gland cancer	0.000192	0.000192	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CREBBP—salivary gland cancer	0.000188	0.000188	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EP300—salivary gland cancer	0.000183	0.000183	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CREBBP—salivary gland cancer	0.000178	0.000178	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CA—salivary gland cancer	0.000169	0.000169	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—salivary gland cancer	0.000163	0.000163	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HRAS—salivary gland cancer	0.000156	0.000156	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.000154	0.000154	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000153	0.000153	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PIK3CA—salivary gland cancer	0.000147	0.000147	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCND1—salivary gland cancer	0.000139	0.000139	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HRAS—salivary gland cancer	0.000136	0.000136	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PIK3CA—salivary gland cancer	0.000135	0.000135	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTEN—salivary gland cancer	0.000134	0.000134	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CREBBP—salivary gland cancer	0.000128	0.000128	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EP300—salivary gland cancer	0.000128	0.000128	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTEN—salivary gland cancer	0.000127	0.000127	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HRAS—salivary gland cancer	0.000125	0.000125	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—EP300—salivary gland cancer	0.000121	0.000121	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CREBBP—salivary gland cancer	9.69e-05	9.69e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CA—salivary gland cancer	9.48e-05	9.48e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—salivary gland cancer	9.17e-05	9.17e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTEN—salivary gland cancer	9.17e-05	9.17e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CREBBP—salivary gland cancer	9.13e-05	9.13e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CA—salivary gland cancer	8.95e-05	8.95e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HRAS—salivary gland cancer	8.77e-05	8.77e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—EP300—salivary gland cancer	8.74e-05	8.74e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTEN—salivary gland cancer	6.92e-05	6.92e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—EP300—salivary gland cancer	6.6e-05	6.6e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTEN—salivary gland cancer	6.52e-05	6.52e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CA—salivary gland cancer	6.47e-05	6.47e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—EP300—salivary gland cancer	6.22e-05	6.22e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CREBBP—salivary gland cancer	5.97e-05	5.97e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CA—salivary gland cancer	4.88e-05	4.88e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	4.6e-05	4.6e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTEN—salivary gland cancer	4.26e-05	4.26e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—EP300—salivary gland cancer	4.06e-05	4.06e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	3.01e-05	3.01e-05	CbGpPWpGaD
